Clinical Trial Update: Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating whether dietary fat levels affect uptake of abiraterone acetate in metastatic hormone-resistant prostate cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Zytiga) (abiraterone acetate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer | Phase 1 | Status: TERMINATED